These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9263355)

  • 21. Long-term use of anagrelide in young patients with essential thrombocythemia.
    Storen EC; Tefferi A
    Blood; 2001 Feb; 97(4):863-6. PubMed ID: 11159509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of anagrelide on megakaryopoiesis and platelet production.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):352-61. PubMed ID: 16810611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of different regimens for initiating anagrelide in patients with essential thrombocythemia who are intolerant or refractory to their current cytoreductive therapy: results from the multicenter FOX study of 177 patients in France.
    Rey J; Viallard JF; Keddad K; Smith J; Wilde P; Kiladjian JJ;
    Eur J Haematol; 2014 Feb; 92(2):127-36. PubMed ID: 24118452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment outcome of patients with essential thrombocythemia at our department in Hungary].
    Iványi JL; Marton É; Plander M; Szendrei T
    Orv Hetil; 2016 Feb; 157(9):336-41. PubMed ID: 26895801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
    Harrison CN; Campbell PJ; Buck G; Wheatley K; East CL; Bareford D; Wilkins BS; van der Walt JD; Reilly JT; Grigg AP; Revell P; Woodcock BE; Green AR;
    N Engl J Med; 2005 Jul; 353(1):33-45. PubMed ID: 16000354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long-term study of young patients with essential thrombocythemia treated with anagrelide.
    Mazzucconi MG; Redi R; Bernasconi S; Bizzoni L; Dragoni F; Latagliata R; Santoro C; Mandelli F
    Haematologica; 2004 Nov; 89(11):1306-13. PubMed ID: 15531452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anagrelide, a novel platelet lowering option in essential thrombocythaemia: treatment experience in 48 patients in Germany.
    Petrides PE; Beykirch MK; Trapp OM
    Eur J Haematol; 1998 Aug; 61(2):71-6. PubMed ID: 9714517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide.
    Tefferi A; Szuber N; Vallapureddy RR; Begna KH; Patnaik MM; Elliott MA; Christopher Hook C; Wolanskyj AP; Hanson CA; Ketterling RP; Pardanani A; Gangat N
    Am J Hematol; 2019 Jan; 94(1):5-9. PubMed ID: 30252953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of essential thrombocythemia with anagrelide.
    Chintagumpala MM; Kennedy LL; Steuber CP
    J Pediatr; 1995 Sep; 127(3):495-8. PubMed ID: 7658287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anagrelide for treatment of patients with essential thrombocythaemia].
    Boban A; Sertić D; Radman I; Zupancić-Salek S; Zadro R; Labar B
    Lijec Vjesn; 2008; 130(5-6):141-5. PubMed ID: 18792562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia.
    Gugliotta L; Tieghi A; Tortorella G; Scalzulli PR; Ciancia R; Lunghi M; Cacciola E; Cacciola R; Candoni A; Crugnola M; Codeluppi K; Usala E; Specchia G; Martinelli V; Palmieri F; Pierri I; Liberati AM; Iurlo A; Grossi A; Vannucchi AM; Vianelli N; Mazzucconi MG
    Leuk Res; 2011 Dec; 35(12):1557-63. PubMed ID: 21764130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anagrelide: new drug. Essential thrombocythaemia: further evaluation needed for this last-resort treatment.
    Prescrire Int; 2006 Jun; 15(83):83-6. PubMed ID: 16764090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin].
    Penka M; Schwarz J; Pavlík T; Indrák K; Doubek M; Dulícek P; Pospísilová D; Kissová J; Jonásová A; Jelínková P; Hlusí A; Schutzová M; Cerná O; Brychtová Y; Nováková L; Korístek Z; Segethová J; Vozobulová V; Hadacová I; Hochová I; Voglová J; Walterová L; Bodzásová C; Dusek L
    Vnitr Lek; 2009 Nov; 55(11):I-XII. PubMed ID: 20017445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of essential thrombocythemia in childhood.
    Scherer S; Ferrari R; Rister M
    Pediatr Hematol Oncol; 2003; 20(5):361-5. PubMed ID: 12775533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment indications and choice of a platelet-lowering agent in essential thrombocythemia.
    Barbui T; Finazzi G
    Curr Hematol Rep; 2003 May; 2(3):248-56. PubMed ID: 12901347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anagrelide-induced changes of megakaryopoiesis during therapy of chronic myeloproliferative disorders with thrombocythemia].
    Thiele J; Kvasnicka HM; Schmitt-Gräff A
    Pathologe; 2002 Nov; 23(6):426-32. PubMed ID: 12436295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anagrelide in primary thrombocythemia].
    Knutsen H; Hysing J
    Tidsskr Nor Laegeforen; 2001 May; 121(12):1478-82. PubMed ID: 11449771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful rechallenge with anagrelide in a patient with anagrelide-associated cardiomyopathy.
    Wong RS; Lam LW; Cheng G
    Ann Hematol; 2008 Aug; 87(8):683-4. PubMed ID: 18299832
    [No Abstract]   [Full Text] [Related]  

  • 39. Anagrelide treatment in myeloproliferative disorders.
    Birgegard G
    Semin Thromb Hemost; 2006 Apr; 32(3):260-6. PubMed ID: 16673280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers.
    Barbui T; Finazzi G; Dupuy E; Kiladjian JJ; Brière J
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():149-60. PubMed ID: 8951786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.